Zobrazeno 1 - 10
of 372
pro vyhledávání: '"anti-obesity drugs"'
Autor:
Branislava Raičević, Ivana Stević, Dragana Lakić, Agnes Männik, Kalina Gjorgjievska, Bojan Labachevski, Kristina Pavlovska, Miodrag Žunić, Petya Milushewa, Guenka Petrova, Dominik Grega, Przemysław Holko, Slobodan M. Janković
Publikováno v:
Biotechnology & Biotechnological Equipment, Vol 38, Iss 1 (2024)
Drugs for the treatment of obesity show significant effectiveness, but the adverse effects (ADRs) of these drugs are numerous and varied, and some of them are highly cost-generating. Our research aimed to define the health care utilization pattern in
Externí odkaz:
https://doaj.org/article/9a8dd63dcb3e4d0084a52f745cecb063
Publikováno v:
Clinical Epidemiology, Vol Volume 16, Pp 307-318 (2024)
Aurélie Mailhac,1 Lars Pedersen,1 Anton Pottegård,2 Jens Søndergaard,3 Torben Mogensen,4 Henrik Toft Sørensen,1 Reimar W Thomsen1 1Department of Clinical Epidemiology, Aarhus University and Aarhus University Hospital, Aarhus, Denmark; 2Clinical P
Externí odkaz:
https://doaj.org/article/e85c7a8708884b2aa17cdcbfe98c72cb
Autor:
Matheo A. M. Stumpf, Marcio C. Mancini
Publikováno v:
Archives of Endocrinology and Metabolism, Vol 68 (2024)
ABSTRACT Obesity is a prevalent chronic disease. The management of extreme obesity – i.e., body mass index (BMI) ≥ 50 kg/m2 or obesity class IV and V – is still far from ideal. Individuals with extreme obesity have a high risk of surgical compl
Externí odkaz:
https://doaj.org/article/cfe29782d66649c8944c6d6466fad029
Publikováno v:
Arhiv za farmaciju, Vol 74, Iss 3, Pp 335-347 (2024)
The global epidemic of obesity has affected almost every country in the world, causing an enormous social and health burden. Although many countermeasures have been introduced against this epidemic, obesity is still on the rise. An important step in
Externí odkaz:
https://doaj.org/article/ee9f866c2e11485f9ca15bcbd5d2d626
Autor:
Walmir Coutinho, Bruno Halpern
Publikováno v:
Diabetology & Metabolic Syndrome, Vol 16, Iss 1, Pp 1-16 (2024)
Abstract Obesity is a chronic, recurring, progressive disease and a major public health problem associated with several other diseases that lead to disability, morbidity, and mortality. The prevalence of obesity has increased at pandemic levels, alon
Externí odkaz:
https://doaj.org/article/231db14e65ab4085b715d98920124204
Autor:
A. V. Vitebskaya, A. V. Popovich
Publikováno v:
Ожирение и метаболизм, Vol 20, Iss 2, Pp 124-130 (2023)
BACKGROUND: Liraglutide was approved for treatment of obesity in children and adolescents since 12 years. Due to gastrointestinal (GI) side effects not all patients reach maximal dose; this can affect the efficacy of obesity treatment.AIM: To study e
Externí odkaz:
https://doaj.org/article/71d6a9088a224e62a23ce0cf0ef82360
Publikováno v:
Pharmacological Research, Vol 200, Iss , Pp 107058- (2024)
Cardiovascular disease (CVD) remains the leading cause of death and disability worldwide. While many factors can contribute to CVD, atherosclerosis is the cardinal underlying pathology, and its development is associated with several metabolic risk fa
Externí odkaz:
https://doaj.org/article/0359eadbe934461280c5803f05d65696
Autor:
Yan Xue, Huimin Zou, Zhen Ruan, Xianwen Chen, Yunfeng Lai, Dongning Yao, Carolina Oi Lam Ung, Hao Hu
Publikováno v:
Frontiers in Endocrinology, Vol 14 (2023)
IntroductionPharmacological therapy is recommended as a second-line alternative to reverse obesity. Currently, five anti-obesity drugs (AODs) have been approved by the U.S. Food and Drug Administration (FDA) for chronic weight management. The aim of
Externí odkaz:
https://doaj.org/article/acd6f7620743429ab8411509a4268263
Publikováno v:
ClinicoEconomics and Outcomes Research, Vol Volume 15, Pp 51-62 (2023)
Nina Kim,1 Joaquin Estrada,2 Isabella Chow,2 Aleksandrina Ruseva,1 Abhilasha Ramasamy,1 Chakkarin Burudpakdee,1 Christopher M Blanchette1 1Novo Nordisk, Inc, Plainsboro, NJ, USA; 2IQVIA, Inc, San Francisco, CA, USACorrespondence: Aleksandrina Ruseva,
Externí odkaz:
https://doaj.org/article/f866cb1820a146f1a211084e3b245e13
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.